Anpario plc
(“Anpario” or the “Company”)
Orego-stim patent granted for reducing antimicrobial resistance
Anpario, the independent manufacturer of natural sustainable animal feed additives for health, nutrition, and biosecurity, is pleased to confirm it has successfully been granted a UK patent for market leading phytogenic product Orego-Stim.
The patent grant follows a combined and successful research programme with the University of Reading. This research shows that the natural oregano oil composition reduces the proportion of bacteria in the gut that show antimicrobial resistance, when added to the diets of young cattle. This resistance can occur when calves are fed 'waste milk' or colostrum containing antibiotic residues. This 'waste milk', which also contains beneficial microbes for metabolism and immunity, is a major by-product of the dairy industry which cannot be sold for human consumption and so instead, is commonly fed to calves.
The inhibition effects of the Orego-Stim on antimicrobial resistance means that those 'highest priority and critically important' antibiotics commonly used in human and animal medicine, such as cephalosporins can be safeguarded for future use. There are other positive aspects to this research which support Anpario's strategy of extending our product technology to maintain animal health through scientific applications.
It is hoped that the UK patent will provide a tax benefit to the Group via the UK Patent Box scheme which allows companies to apply a lower rate of corporation tax to profits attributable to qualifying patents. We are currently working with our tax and patent advisors to clarify the scope of qualifying profits and the tax benefit.
Further details regarding the research trial can be found on the following link: https://www.anpario.com/media/news/university-trial-shows-anparios-orego-stim-can-help-reduce-antimicrobial-resistance-in-calves/